Understanding miRNA Turnover: A Study of miRNA Half-Life

Slides:



Advertisements
Similar presentations
NcRNA Structural 1.rRNA 2.tRNA 3.snRNA 4.snoRNA 5.cleavage: Rnases P & MRP, U3, snR30, etc Regulatory 1.Small siRNA miRNA 2.Long Activator Enhancer silencing.
Advertisements

Doug Brutlag 2011 Genomics, Bioinformatics & Medicine Doug Brutlag Professor Emeritus of.
The Eli and Edythe L. Broad Institute A Collaboration of Massachusetts Institute of Technology, Harvard University and affiliated Hospitals, and Whitehead.
Computational Analysis of the Taxanomical Classification of Short 16S rRNA Sequences Christel Chehoud Mentor: Brian Haas.
MiRNA Platform Overview The Agilent miRNA Microarray System A New Microarray-based Tool for Profiling Human miRNAs.
Translational Inhibition in Arabidopsis thaliana Russell Burke Dr. James Carrington Botany and Plant Pathology.
MiRNA targets Using undergraduate molecular biology labs to discover targets of miRNAs in humans Adam Idica, Jordan Thompson, Irene Munk Pedersen, Pavan.
Chapter 15 Noncoding RNAs. You Must Know The role of noncoding RNAs in control of cellular functions.
UTR motifs and microRNA analysis 曾 大 千 助 理 教 授 10/28/2008.
“Discovery Of Gene Ripple Effect Which Causes Cervical Cancer to Advance And Spread” May 19 th, 2011
Transfection. What is transfection? Broadly defined, transfection is the process of artificially introducing nucleic acids (DNA or RNA) into cells, utilizing.
Luke Alden Yancy, Jr. Mentor: Robert Riley Broad Institute of MIT & Harvard Cambridge, MA.
Identifying and classifying functional small RNAs from pine Ryan Morin BC Genome Sciences Centre (presenting research conducted in the lab of Dr. Peter.
Sequencing TRAF1 in patients with rheumatoid arthritis Bruce C. Jobse Medical and Population Genetics Broad Institute.
Small molecule-induced pancreatic exocrine transdifferentiation: Assay development Kristin Rose Bridget Wagner, Ph.D. Broad Chemical Biology, Broad Institute.
Arthur Edwards Broad Summer Research Program in Genomics Cancer Program 08/06/07 Genome-wide miRNA Expression Analysis in Lymphoma miRNAs Lymphoma.
Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey ISMB 2010 MicroRNA Mike needs help to degrade all the mRNA transcripts!
1.Biography 2. Project 3. Success 4. References. Name: Sid Altman Birth date: May 7, 1939 Birth place: Montreal, Quebec Residence: New Haven, Connecticut.
In recent years, numerous studies have documented transcription across 70–90% of the human genome. 2% of the total genome encodes protein-coding genes,
Computational Molecular Biology Biochem 218 – BioMedical Informatics miRNA Regulatory.
Predicting MicroRNA Genes and Target Site using Structural and Sequence Features: Machine Learning Approach Malik Yousef Institute of Applied Research,
Invitrogen Corporation 1600 Faraday Ave. Carlsbad, CA USA Tel: FAX: Toll Free Tel:
Christopher Dickman Cathie Garnis Experimental Medicine Research Day
Defective post-transcriptional gene regulation Neil Renwick MD, PhD Laboratory of Translational RNA Biology Department of Pathology and Molecular Medicine.
What is RNA interference?
Drosha. 121th Lab meeting 석사 2 년 박 은 실.
吳 華 席 Hua-Hsi Wu, MD OB/GYN, VGH-TPE Aug 12, 2008
Apostolos Zaravinos and Constantinos C Deltas Molecular Medicine Research Center and Laboratory of Molecular and Medical Genetics, Department of Biological.
MicroRNA regulation in Arabidopsis thaliana
SmallRNAs Small molecules, big functions. Brief history The first described microRNA, lin-4 was cloned and characterised as a translational repressor.
Youngae Lee Identification of microRNA function by target prediction and expression profiling.
Control of Gene Expression
HIGH-THROUGHPUT MUTATION PROFILING OF OSTEOSARCOMA PRIMARY TUMORS AND CELL LINES IDENTIFIES NEW MUTATIONS IN PREVIOUSLY UNASSOCIATED ONCOGENES AND TUMOR.
Search for novel non-coding RNAs in prostate carcinoma cells Christine Schulz AG RNomics.
Last class Plasmid isolation from bacteria Paper 2: miRNAs in iPSCs.
Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th.
AP Biology Control of Prokaryotic (Bacterial) Genes.
Characterization of Small Molecule ETS Transcription Factor Binders Nicole M. Martinez Marius S. Pop and Levi A. Garraway Cancer Biology Program.
Introduction Results Conclusions Acknowledgements Alzheimer’s Disease (AD) is the most common chronic degenerative neurological disease, and there are.
Affymetrix microarray analysis by using Cmap By NFU Biology Algorithm lab.
Project: Cellular microRNA profilings during the infections of the hepatitis C virus and the influenza A virus Yu Li Postdoc Fellow Katze Lab.
Javad Jamshidi Fasa University of Medical Sciences, November 2015 Gene Structure and Transcriptio n.
The Contribution of Ploidy to Functional Genomic Comparisons in Yeasts Eric Delgado Regev Group Summer Research Program in Genomics.
Predicting patterns of biological performance using chemical substructure features Diego Borges-Rivera 08/04/08.
Homework #2 is due 10/17 Bonus #1 is due 10/24 Exam key is online Office hours: M 10/ :30am 2-5pm in Bio 6.
Regulatory Relationship of microRNAs in Alzheimer and Huntington Diseases: A Cladistics Approach Prachi Srivastava AMITY Institute of Biotechnology AMITY.
NCode TM miRNA Analysis Platform Identifies Differentially Expressed Novel miRNAs in Adenocarcinoma Using Clinical Human Samples Provided By BioServe.
Human cytomegalovirus (HCMV) is a member of the herpesvirus family. About 70-90% of the population is infected with HCMV. In healthy.
Agenda  Epigenetics and microRNAs – Update –What’s epigenetics? –Preliminary results.
Mestrado Integrado em Medicina Biologia Celular e Molecular II
Translation. The enzyme: Amminoacyl-tRNA synthetase.
Last class Overall goal for labs 7-9 How to pick candidate miRNA targets Overview: “Validate” target prediction.
CASE 3 ——Maize Genome-Wide and Organ-Specific Landscapes of Epigenetic Modifications and Their Relationships to mRNA and Small RNA Transcriptomes in Maize.
Sapana Shinde, Aaron Ripley, Dr. Sok Kean Khoo MicroRNA expression studies in rotenone- induced cellular model for Parkinson’s disease Department of Cell.
AP EXAM REVIEW SESSION MOLECULAR GENETICS Be prepared, not scared!
N. Zhong, J. Sun, Z. Min, W. Zhao, R. Zhang, W. Wang, J. Tian, L
Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma  Jun Wang, MD, PhD, Zhi Li, MD, PhD,
Altered microRNA expression in stenoses of native arteriovenous fistulas in hemodialysis patients  Lei Lv, MD, Weibin Huang, MD, Jiwei Zhang, MD, Yaxue.
Velizar Shivarov, Lars Bullinger  Experimental Hematology 
MicroRNAs: Key Modulators of Posttranscriptional Gene Expression
Reactive oxygen species inhibit miR‐199a and miR‐125b expression levels in vitro and in vivo. Reactive oxygen species inhibit miR‐199a and miR‐125b expression.
Computational Discovery of miR-TF Regulatory Modules in Human Genome
Jamila Horabin Biomedical Sciences
Microarray analysis of phospho-Twist1–responsive genes.
Volume 154, Issue 3, Pages (February 2018)
Noncoding RNA roles in Gene Expression
MicroRNAs Dysregulation in Human Malignant Pleural Mesothelioma
Long Noncoding RNAs and Hepatocellular Carcinoma
CCG regulates cellular localization and blocks target gene expression of MRTF. A, SK-Mel-147 cells were cotransfected with RhoC and the SRE.L reporter.
The AKT–mTOR pathway controls PD-L1 protein expression.
Presentation transcript:

Understanding miRNA Turnover: A Study of miRNA Half-Life Dominic McDonald Massachusetts Institute of Technology Mentor: Jun Lu, Ph. D Todd Golub Laboratory Broad Institute of MIT and Harvard Better titles.

What are miRNAs? miRNAs are short non-coding RNAs Post-transcriptional regulators of gene expression miRNAs regulate diverse biological and disease processes

miRNA Biogenesis Talk about: 20-25 nucleotide single stranded RNA molecules; first discovered in 1993 in C.Elegans by Lee, Feinbaum, and Ambros; major role in biological systems is gene regulations; Has been known to be possible causes to cancer because the miRNA may inhibit a gene from translating proteins that may induce apoptosis, metastasis, or that prevents cell proliferation; Not much is known about miRNA turnover and how fast they degrade Zamore PD & Haley B. Science 2005

How do miRNAs turnover? Put more space between words, background information as to why it is important. The Big Picture Purpose. Possible applications

Approach to Measure miRNA t1/2 Culture Cells in Triplicates Treat Cells with Actinomycin D Harvest RNA at 6 time points throughout the day Actinomycin-D is an antibiotic which binds to DNA and prevents RNA synthesis, therefore no more RNA molecules are being produced. We then harvest the RNA at different timepoints with TriZOL, and then using RT-PCR are able to measure the gene expression levels at each of the timepoints which then can be used as a marker to see the degradation of miRNA. Actinomycin-D has it’s problems as it is very toxic to the cells and will kill them within a day. Therefore this method can only be used during the course of 1 day. To measure longer periods we need to use an inducible system. The system we chose to use is the Tet-Off system. Measure miRNA and control gene expression levels using Luminex NextGen and RT-PCR

Cell Lines Maintained 26 different cancer cell lines. Due to time constraints only able to collect data from 9 different cancer cell lines: HD-MY-Z, 697, HL60, K562, Ramos (RA1), RS4;11, SEMK2, U937, and HEL cell lines. Triplicates of every cell line done at 6 time points each for a total of 162 samples.

Control Gene Degradation c-myb These graphs show that using treatment with Actinomycin-D does work. These 2 genes, c-myb and c-myc both have known half lives of less than 2 hours. In all 6 cancer cell lines, both genes are shown to have 50% degradation before 2 hours. Therefore this validates our sample quality

Control Gene Degradation c-myb This is the log 2 graph of the data. We were able to calculate half life by taking the inverse of the slope. For the rest of my presentation this is how I will be presenting the information compared to the previous slide.

Control Gene Degradation c-myc These graphs show that using treatment with Actinomycin-D does work. These 2 genes, c-myb and c-myc both have known half lives of less than 2 hours. In all 6 cancer cell lines, both genes are shown to have 50% degradation before 2 hours. Therefore this validates our methodology.

MicroRNA Profiling Used Luminex NextGen Lu, J Nature 2005

RT-PCR Validation Use additional methodology to validate results Use RT-PCR for validation Measure miR-125a in K562 cells Measure u6 small RNA as a control

RT-PCR Validation To confirm this data we ran the RNA samples from some cell lines using RT-PCR to see if the data matched using a different method. Here is an example of HD-MY-Z using RT-PCR. The reason why the data is going up, as if there is more miRNA being produced is because the control gene, u6, is being degraded and miR-125a is not being degraded, therefore causing an upward curve. If you look at the raw data, the amount of miR-125a remains constant throughout all of the timepoints.

RT-PCR Validation

RT-PCR Validation

What Does This All Mean? Most miRNAs have long t1/2 (over 24 hours) We have not observed any fast degrading miRNAs (t1/2 less than 8 hours)

Why would nature create a class of stable cellular regulators? Question pose to the audience. Most regulators share very short half-lives to be easily manipulated to. What could be possible reasons as to why miRNAs degrade very slow. Put forth the possibility that miRNAs are so small that there is not a mechanism that can degrade the microRNA fast.

Acknowledgements Our Team: Jun Lu Hao Zhang Judy Wang Golub Lab: Todd Golub Jinyan Du Broad Institute: Shawna Young Bruce Birren Lucia Vielma Maura Silverstein